2018
DOI: 10.1016/j.transproceed.2017.11.060
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Value of Blood Panel Parameters in Patients With Dilated Cardiomyopathy and Advanced Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…We identified 17 studies analysing mortality in DCM since the 1980s up to the present. [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] The reported mortality rate varied from 6% (reported by Marume et al) to 43% (from Sobrino-Márquez et al). Overall, the studies differ fundamentally, especially in terms of the dates (from 1978 to 2017), the duration of observation (from 1 to over 9 years), the number of recruited patients (from 87 to 881-on average, 350 patients-while one Japanese study looked at 1554 patients).…”
Section: Overview Of Prognostic Studies In Dilated Cardiomyopathymentioning
confidence: 99%
See 2 more Smart Citations
“…We identified 17 studies analysing mortality in DCM since the 1980s up to the present. [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] The reported mortality rate varied from 6% (reported by Marume et al) to 43% (from Sobrino-Márquez et al). Overall, the studies differ fundamentally, especially in terms of the dates (from 1978 to 2017), the duration of observation (from 1 to over 9 years), the number of recruited patients (from 87 to 881-on average, 350 patients-while one Japanese study looked at 1554 patients).…”
Section: Overview Of Prognostic Studies In Dilated Cardiomyopathymentioning
confidence: 99%
“…The reason for this is that the available data were gathered quite a few years ago; the mortality rate findings also vary widely (from 6% to 43%). [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] Moreover, apart from the score created by Miura et al based on a Japanese cohort from the 1990s, there is no prognostic model specific to mortality in DCM patients. 22 In addition, the Miura et al score was created in different therapy settings and has not been validated on a European DCM population.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, regarding prognosis, during a five-year follow-up of a small HF group with advanced idiopathic or familial dilated cardiomyopathy evaluated for non-urgent heart transplant, Sobrino-Marquez et al found no correlation of median NLR on initial work-up with survival or necessity for surgical intervention [33].…”
Section: Dilated Cardiomyopathymentioning
confidence: 99%
“…In neutropenia, activity of proinflammatory cytokines and growth factors to maintain the angiogenic and fibrogenic capacity could be disrupted. These would be the reasons behind mild changes shown in the myocardium of the rats (Black and Heynick 2003;Huang and Mold 1980;Sobrino-Marquez et al 2018).…”
Section: Discussionmentioning
confidence: 99%